Protagonist Therapeutics Inc (NQ: PTGX )
20.95 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2023 Add to My Watchlist
All News about Protagonist Therapeutics Inc
With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors.
Topics Initial Public Offering
Exposures Securities Market